GlassScriptPhysician profile
Veena Patel
NPI 1942528286
$6,290.46
in general payments reported to CMS, 2019-2025
44 companies · $784 in 2025
The $784 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $648 · 2021: $565 · 2022: $1,000 · 2023: $1,097 · 2024: $1,331 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,212.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $797.79 | 2019-2025 | |
| Abbvie INC. | $707.92 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $681.82 | 2019-2025 | Ultomiris, Soliris |
| Ucb, INC. | $547.54 | 2019-2025 | Zilbrysq, Rystiggo, Fintepla |
| Supernus Pharmaceuticals, INC. | $504.80 | 2019-2021 | |
| Biogen, INC. | $336.79 | 2019-2024 | Tysabri, Vumerity |
| Takeda Pharmaceuticals U.S.A., INC. | $295.46 | 2022-2025 | Hyqvia |
| Emd Serono, INC. | $237.20 | 2020-2025 | Mavenclad |
| Amgen INC. | $183.88 | 2019-2024 | Uplizna |
| Janssen Pharmaceuticals, INC | $174.52 | 2020-2022 | |
| Mdd US Operations, LLC | $149.12 | 2023-2025 | Gocovri, Apokyn, Gocovri |
| Lilly USA, LLC | $140.38 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Lundbeck LLC | $122.89 | 2019-2025 | Vyepti |
| Livanova USA, INC. | $117.11 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Allergan, INC. | $109.18 | 2020-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veena Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.